The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory CommitteeElı́as Campo, Andrew D. Zelenetz, Ari Melnick et al.|Blood|2022Cited by 1.5k
Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune CellsSandeep S. Davé, Louis M. Staudt, George W. Wright et al.|New England Journal of Medicine|2004Cited by 1.4k
Subcutaneous Rituximab for the Treatment of B-Cell Hematologic Malignancies: A Review of the Scientific Rationale and Clinical DevelopmentAndrew Davies, Xavier C. Badoux|Advances in Therapy|2017Cited by 63
Results of a United Kingdom real-world study of polatuzumab vedotin, bendamustine, and rituximab for relapsed/refractory DLBCLMichael Northend, William Townsend, William Wilson et al.|Blood Advances|2022Cited by 44
Comparison of MHG and DZsig reveals shared biology and a core overlap group with inferior prognosis in DLBCLJohn R. Davies, David W. Scott, Laura K. Hilton et al.|Blood Advances|2023Cited by 14